| 1 |
34875337 | Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a mouse Leydig tumor cell line. | 2022 Feb 15 |
1 |
| 2 |
32299297 | E-pharmacophore based virtual screening for identification of dual specific PDE5A and PDE3A inhibitors as potential leads against cardiovascular diseases. | 2021 Apr |
1 |
| 3 |
25505249 | The unexpected evolution of basic science studies about cyclic nucleotide action into a treatment for erectile dysfunction. | 2015 Jan 16 |
1 |
| 4 |
23490535 | Phosphodiesterase type 1, calcitonin gene-related peptide and vasoactive intestinal polypeptide are involved in the control of human vaginal arterial vessels. | 2013 Jul |
1 |
| 5 |
23961322 | Diabetic nephropathy: Treatment with phosphodiesterase type 5 inhibitors. | 2013 Aug 15 |
2 |
| 6 |
23986226 | Synergistic effects of prostacyclin analogs and phosphodiesterase inhibitors on cyclic adenosine 3',5' monophosphate accumulation and adenosine 3'5' triphosphate release from human erythrocytes. | 2013 Sep |
1 |
| 7 |
21905762 | Novel phosphodiesterase type 5 modulators: a patent survey (2008 - 2010). | 2011 Oct |
1 |
| 8 |
20491634 | PDE5 inhibitors and their applications. | 2010 |
1 |
| 9 |
19560695 | Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition. | 2009 Jul |
1 |
| 10 |
20004158 | Cyclic nucleotide binding GAF domains from phosphodiesterases: structural and mechanistic insights. | 2009 Dec 9 |
1 |
| 11 |
18234184 | PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries. | 2008 Mar 17 |
1 |
| 12 |
18467075 | Real-time monitoring of phosphodiesterase inhibition in intact cells. | 2008 Aug |
1 |
| 13 |
17604974 | [PDE5 inhibitors. A new option in the treatment of ureteral colic?]. | 2007 Sep |
1 |
| 14 |
10506154 | Studies of the molecular mechanism of discrimination between cGMP and cAMP in the allosteric sites of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). | 1999 Oct 8 |
2 |
| 15 |
10611481 | A cyclic nucleotide PDE5 inhibitor corrects defective mucin secretion in submandibular cells containing antibody directed against the cystic fibrosis transmembrane conductance regulator protein. | 1999 Dec 24 |
2 |
| 16 |
9218482 | The regulation of the cGMP-binding cGMP phosphodiesterase by proteins that are immunologically related to gamma subunit of the photoreceptor cGMP phosphodiesterase. | 1997 Jul 18 |
1 |